Other Assets

Other assets consist of the following:



	December 31, 2014		December 31, 2013
	(In thousands)
Capitalized software development costs, net of accumulated amortization of $14,918 and $10,547, respectively, and accumulated impairment ⁽¹⁾	$	19,643	$	13,660
Technology license	1,678		2,350
Long-term deposits	860		682
Other long-term assets ⁽²⁾	1,092		1,245
Total other long-term assets	$	23,273	$	17,937

_________________________________________________

⁽¹⁾

In the first quarter of 2013, we reorganized our management team as part of the continuing integration of MTS, including the software development department within the Medication Adherence segment. At this time, $1.8 million was capitalized as software development costs associated with a software solution that was intended to assist pharmacies in manual packaging of prescriptions. Our management team reassessed the viability of this project and the net realizable value of the capitalized costs in light of their decision to change the related product road map and redesign this product based on evolving market demands. As part of this redesign process, new functionality and capabilities were needed to be added to the product before commercialization. This redesign was intended to provide a more robust global platform providing larger scalability and significant functionality not contained in the then-current beta version. We determined we could no longer support the technological feasibility of this project in conjunction with our software capitalization policy. Therefore, we abandoned the project and wrote off its net book value of $1.8 million, equating to $0.03 per diluted share, net of tax, which was recorded as an expense of research and development in our Consolidated Statements of Operations.


⁽²⁾	Other long-term assets primarily include our equity investments. In the fourth quarter of 2014, we determined our equity investment accounted for under the cost method of accounting is no longer considered realizable, and therefore wrote off its net book value of $0.4 million as a non-operating expense in our Consolidated Statements of Operations.